Breakthrough Candidate in the Fight Against Malaria A new antimalarial drug candidate, MK-7602, is showing early promise in addressing two of the most pressing challenges in malaria control: rising drug resistance and ongoing transmission. Developed as a first-in-class clinical candidate, MK-7602 represents a strategic advance in the global effort to reduce malaria morbidity and move…